These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 15791889)

  • 1. Mildly elevated liver transaminase levels in the asymptomatic patient.
    Giboney PT
    Am Fam Physician; 2005 Mar; 71(6):1105-10. PubMed ID: 15791889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Causes and evaluation of mildly elevated liver transaminase levels.
    Oh RC; Hustead TR
    Am Fam Physician; 2011 Nov; 84(9):1003-8. PubMed ID: 22046940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interpretation of hypertransaminasemia].
    Othmani S; Bahri M; Bahri M
    Tunis Med; 2002 May; 80(5):236-44. PubMed ID: 12534025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mildly Elevated Liver Transaminase Levels: Causes and Evaluation.
    Oh RC; Hustead TR; Ali SM; Pantsari MW
    Am Fam Physician; 2017 Dec; 96(11):709-715. PubMed ID: 29431403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Special considerations in interpreting liver function tests.
    Johnston DE
    Am Fam Physician; 1999 Apr; 59(8):2223-30. PubMed ID: 10221307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of asymptomatic elevated serum aminotransferase levels, particularly in nonalcoholic steatohepatitis].
    Oldenburg B; Van Berge Henegouwen GP
    Ned Tijdschr Geneeskd; 1999 Mar; 143(10):506-9. PubMed ID: 10321258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver dysfunction in children and adolescents during hemodialysis and after renal transplantation.
    Fennell RS; Andres JM; Pfaff WW; Richard GA
    Pediatrics; 1981 Jun; 67(6):855-61. PubMed ID: 6262705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of abnormal liver tests.
    Fregia A; Jensen DM
    Compr Ther; 1994; 20(1):50-4. PubMed ID: 8137620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficient diagnostics for elevated transaminases].
    Folwaczny C
    MMW Fortschr Med; 2007 Jul; 149(29-30):44-8; quiz 49. PubMed ID: 17703692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycogenic hepatopathy: a rare cause of elevated serum transaminases in diabetes mellitus.
    van den Brand M; Elving LD; Drenth JP; van Krieken JH
    Neth J Med; 2009 Dec; 67(11):394-6. PubMed ID: 20009116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, aetiology and associated co-morbidities of elevated aminotransferases in a german cohort of orthopaedic surgery patients.
    Lobstein S; Kaiser T; Liebert U; Wojan M; Leichtle A; Mössner J; Wiegand J; Tillmann HL
    Z Gastroenterol; 2008 May; 46(5):415-20. PubMed ID: 18461515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical tests in evaluation of liver function.
    Skrede S; Blomhoff JP; Elgjo K; Gjone E
    Scand J Gastroenterol Suppl; 1973; 19():37-46. PubMed ID: 4515640
    [No Abstract]   [Full Text] [Related]  

  • 13. Approach to the patient with abnormal liver tests.
    Mahl TC
    Lippincotts Prim Care Pract; 1998; 2(4):379-89. PubMed ID: 9709083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The liver in systemic lupus erythematosus.
    Miller MH; Urowitz MB; Gladman DD; Blendis LM
    Q J Med; 1984; 53(211):401-9. PubMed ID: 6484120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002.
    Ioannou GN; Boyko EJ; Lee SP
    Am J Gastroenterol; 2006 Jan; 101(1):76-82. PubMed ID: 16405537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should patients with type 2 diabetes and raised liver enzymes be referred for further evaluation of liver disease?
    Hickman IJ; Russell AJ; Prins JB; Macdonald GA
    Diabetes Res Clin Pract; 2008 Apr; 80(1):e10-2. PubMed ID: 18187226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
    Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of clinical examination findings, laboratory values, and liver biopsy findings in liver diseases].
    Barousch R; Spina K
    Wien Med Wochenschr; 1974 Dec; 124(50):729-32. PubMed ID: 4462305
    [No Abstract]   [Full Text] [Related]  

  • 19. [Results of using a simple cybernetic method for the evaluation of the information capacity of several biochemical tests in chronic diffuse liver diseases].
    Bliuger AF; Krupnikova EZ; Golubev IS; Raĭtsis AB
    Ter Arkh; 1969; 41(10):81-5. PubMed ID: 5359353
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term prognosis of nonalcoholic fatty liver disease: is pharmacological therapy actually necessary?
    Cinar K; Coban S; Idilman R; Tuzun A; Sarioglu M; Bektas M; Erden E; Bozkaya H; Ozden A
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):169-73. PubMed ID: 16706829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.